Sonoma Biotherapeutics key facts
as of Oct 2026- It has raised $265.0M across 1 recorded rounds; the latest was Early Stage VC (Series B) ($265.0M) in Aug 2021.
- 2 institutional filers report fund marks on Sonoma Biotherapeutics across 36 filings.
- Sonoma Biotherapeutics has filed 1 Form D with the SEC, most recently Aug 2021 ($265.0M sold to 40 investors).
- ·Watch Sonoma Biotherapeutics: the Monday email on marks, rounds and moves
Institutional fund marks on Sonoma Biotherapeutics
2 filers · latest Jul 20262 SEC-registered funds reported 36 fair-value marks on Sonoma Biotherapeutics between Apr 2025 and Jul 2026. Filer-level marks and implied $/share are available to Pro members.
Membership and data by Private Market View
Sonoma Biotherapeutics funding rounds
1 roundsRecent activity
In the last 90 days, Sonoma Biotherapeutics's record added 6 institutional fund marks (latest period Jul 2026).
How much has Sonoma Biotherapeutics raised?
Sonoma Biotherapeutics has raised $265 million across 1 recorded round since 2021. The largest was a $265 million Series B in Aug 2021.
Sonoma Biotherapeutics has filed 1 Form D with the SEC, most recently in Aug 2021 ($265 million sold to 40 investors).
Institutional holders and vehicles
2 SEC-registered funds reported 36 fair-value marks on Sonoma Biotherapeutics between Apr 2025 and Jul 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.
About Sonoma Biotherapeutics
- Industry
- Drug Discovery
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.